Cancer biomarkers: the role of structured data reporting

Ross W Simpson1, Michael A Berman, Philip R Foulis

  • 1From the Department of Pathology, Park Nicollet-Methodist Hospital, St Louis Park, Minnesota (Dr Simpson); the Department of Pathology, Jefferson Regional Medical Center, Jefferson Hills, Pennsylvania (Dr Berman); the University of South Florida Department of Pathology and Cell Biology, James A. Haley Veterans' Hospital, Tampa (Dr Foulis); the Department of Laboratory Medicine, Grand River Hospital, Kitchener, Ontario, Canada (Dr Divaris); the Department of Pathology, Grady Health System/Emory University School of Medicine, Atlanta, Georgia (Dr Birdsong); Capability & Specialty Advancement, College of American Pathologists, Northfield, Illinois (Drs Mirza, Moldwin, and Spencer); the Laboratory Medicine and Genetics Program, Trillium Health Partners, Mississauga, Ontario, Canada (Dr Srigley); and the Department of Pathology, St Jude Medical Center, Fullerton, California (Dr Fitzgibbons).

Summary

Structured electronic cancer checklists improve cancer reporting by standardizing data. This enables better use of cancer biomarker information for pathologists, clinicians, and patients.